Cargando…
Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers
INTRODUCTION: Epithelial–mesenchymal transition (EMT) and mesenchymal–epithelial transition (MET) facilitate breast cancer (BC) metastasis; however, stable molecular changes that result as a consequence of these processes remain poorly defined. Therefore, with the hope of targeting unique aspects of...
Autores principales: | Wendt, Michael K, Taylor, Molly A, Schiemann, Barbara J, Sossey-Alaoui, Khalid, Schiemann, William P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053226/ https://www.ncbi.nlm.nih.gov/pubmed/24618085 http://dx.doi.org/10.1186/bcr3623 |
Ejemplares similares
-
Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition Facilitates Epidermal Growth Factor-Dependent Breast Cancer Progression
por: Wendt, Michael K., et al.
Publicado: (2010) -
Targeted Deletion of Kindlin-2 in Mouse Mammary Glands Inhibits Tumor Growth, Invasion, and Metastasis Downstream of a TGF-β/EGF Oncogenic Signaling Pathway
por: Wang, Wei, et al.
Publicado: (2022) -
The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer
por: Bledzka, Kamila, et al.
Publicado: (2017) -
The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β
por: Sokol, Jonathan P, et al.
Publicado: (2005) -
Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
por: Wendt, Michael K., et al.
Publicado: (2011)